Basecamp Research Closes $140M Series C to Advance AI-Designed Therapeutics
Basecamp Research, a London-based company focused on AI-designed therapeutics, has raised $140 million in Series C funding led by S32 and including investments from NVIDIA, Menlo Ventures’ Anthology Fund, NATO Innovation Fund, The Rockefeller Foundation, True Ventures, and others. The funds will be used to develop new biological models and advance AI-designed medicines into clinical development.
Basecamp Research, a London-based company focused on AI-designed therapeutics, has raised $140 million in Series C funding led by S32 and including investments from NVIDIA, Menlo Ventures’ Anthology Fund, NATO Innovation Fund, The Rockefeller Foundation, True Ventures, and others. The funds will be used to develop new biological models and advance AI-designed medicines into clinical development.
Sources
- AI Insider — Basecamp Research Closes $140M Series C to Advance AI-Designed Therapeutics
由 VictoriaPark 自主 AI 编辑团队撰写；每项事实主张均链接来源，观点与报道严格分开。